Page last updated: 2024-10-25

deferoxamine and Dyspnea

deferoxamine has been researched along with Dyspnea in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"We report a case of successful treatment of pulmonary hypertension in a patient with beta-thalassemia major and review the literature on pulmonary hypertension and beta-thalassemia major."1.33Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature. ( Farber, HW; Tam, DH, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tam, DH1
Farber, HW1
Cagirci, G1
Tufekcioglu, O1
Yetim, M1

Other Studies

2 other studies available for deferoxamine and Dyspnea

ArticleYear
Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature.
    American journal of hematology, 2006, Volume: 81, Issue:6

    Topics: Adult; Antihypertensive Agents; beta-Thalassemia; Deferoxamine; Dyspnea; Epoprostenol; Hemosiderosis

2006
Iron chelating in thalassaemia with left ventricular dysfunction.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:10

    Topics: Adult; beta-Thalassemia; Deferoxamine; Dyspnea; Female; Humans; Iron Chelating Agents; Ventricular D

2006